The UGDH knockdown strategies have been proposed to evaluate the role of a potential modulator of breast cancer behavior [52], considering that this reduces the intracellular UDP-GlcUA availability and therefore modulation of ECM composition at PGs and GAGs levels, which are implicated in tumor progression. Here, UGDH is linked to breast cancer.